QTREX Quantum Secures $1 Million Grant for Quantum Material Development
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 09 2026
0mins
Source: Newsfilter
- Grant Support: The Israel Innovation Authority awarded QTREX approximately $1 million to support the development of a purpose-built dielectric material aimed at addressing the high-density, low-loss RF signal routing needs in superconducting quantum computing systems, thereby advancing quantum computing infrastructure.
- Material Engineering Breakthrough: The material QTREX is developing will serve as a native layer within its quantum connectivity architecture, allowing the company to integrate dielectric, conductor, and 3D geometry design rather than relying on off-the-shelf materials, thus enhancing signal transmission efficiency and reducing signal loss.
- Industry Bottleneck Resolution: As superconducting quantum processors scale, connectivity becomes a system-level bottleneck, and QTREX's innovative materials and AM capabilities will provide cleaner signal paths and lower thermal impacts for more qubits, addressing the future demands of quantum computing.
- Strategic Market Positioning: QTREX's CEO stated that the grant will strengthen a core materials layer in its quantum connectivity architecture, indicating the company's commitment to developing a new connectivity architecture to meet the physical demands of scalable quantum computing, thereby enhancing its market competitiveness.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy IINN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on IINN
About IINN
Inspira Technologies Oxy B.H.N Ltd, formerly Insense Medical Ltd, incorporated on February 27, 2018, is a specialty medical device company based in Israel. The Company is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). It provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Technical Breakthrough: QTREX has successfully produced a cryogenic chip carrier using its proprietary single-build Additively Manufactured Electronics (AME) process, marking an expansion of its role within the quantum hardware ecosystem into the processor-interface layer, demonstrating that its platform can handle both signal transport and critical carrier functions, thereby enhancing the company's competitiveness in quantum computing infrastructure.
- Market Demand: As quantum systems scale, the importance of QTREX's cryogenic chip carrier in signal distribution and management increases, which is expected to meet the growing demand for higher channel counts and denser routing, further driving the company's growth potential in the quantum hardware market.
- Integration Advantages: The carrier utilizes a Kapton-class polyimide architecture suitable for very low-temperature environments, and the single-build AME process allows for the integrated production of the carrier and interconnect structure, reducing potential failure points and simplifying the signal path, thus supporting higher routing density and improving product reliability.
- Future Outlook: QTREX plans to showcase the chip carrier sample during the Quantum.Tech World 2026 event on June 25-26, 2026, and will focus on customer-specific cryogenic chip carrier designs tailored to individual processor architectures, further solidifying its market position in the quantum computing sector.
See More
- Successful Production Transition: QTREX's Additively Manufactured Electronics (AME) system has successfully transitioned from a development environment to the production floor of a major U.S. interconnect manufacturer, marking a significant commercial and technological milestone for the company in quantum computing infrastructure.
- High Yield Validation: The AME manufacturing process achieved a 97% yield after hundreds of technical and process evaluations, demonstrating its reliability and efficiency in producing high-density interconnect structures, thus meeting advanced electronics manufacturers' demands for higher-density interconnects.
- Addressing Market Demands: As electronics manufacturers face increasing requirements for signal integrity and thermal management, QTREX's AME technology addresses challenges that conventional manufacturing methods struggle to meet by enabling complex 3D structures that integrate dielectric and conductive materials, enhancing its competitive position in the market.
- Strategic Collaboration Prospects: The production deployment supports broader collaboration with leading quantum companies and advanced electronics customers, further advancing high-performance connectivity and quantum infrastructure applications, thereby solidifying QTREX's unique position in the industry.
See More
- Grant Support: The Israel Innovation Authority awarded QTREX approximately $1 million to support the development of a purpose-built dielectric material aimed at addressing the high-density, low-loss RF signal routing needs in superconducting quantum computing systems, thereby advancing quantum computing infrastructure.
- Material Engineering Breakthrough: The material QTREX is developing will serve as a native layer within its quantum connectivity architecture, allowing the company to integrate dielectric, conductor, and 3D geometry design rather than relying on off-the-shelf materials, thus enhancing signal transmission efficiency and reducing signal loss.
- Industry Bottleneck Resolution: As superconducting quantum processors scale, connectivity becomes a system-level bottleneck, and QTREX's innovative materials and AM capabilities will provide cleaner signal paths and lower thermal impacts for more qubits, addressing the future demands of quantum computing.
- Strategic Market Positioning: QTREX's CEO stated that the grant will strengthen a core materials layer in its quantum connectivity architecture, indicating the company's commitment to developing a new connectivity architecture to meet the physical demands of scalable quantum computing, thereby enhancing its market competitiveness.
See More
- Technology Showcase: QTREX will present its AME-based monolithic connectivity components designed for cryogenic interconnect challenges at Quantum.Tech World 2026 on June 25-26, 2026, demonstrating high-density signal routing and complex 3D architectures, which are expected to advance quantum computing infrastructure.
- Industry Meetings: The company will conduct private, invitation-only meetings with industry leaders, research institutions, and strategic partners during the conference, aiming to attract potential collaborators and strengthen industry ties through showcasing its proprietary AME platform components, thereby enhancing market competitiveness.
- Market Positioning: QTREX's participation reflects its position at the hardware frontier of quantum computing infrastructure, addressing interconnect challenges that constrain scalability, indicating the company's capability to additively manufacture such high-spec components globally, potentially laying the groundwork for future market expansion.
- Diversified Development: In addition to quantum technology, QTREX is advancing its medical technology portfolio, including respiratory support and blood monitoring platforms, demonstrating the company's strategic positioning across multiple critical sectors aimed at achieving long-term growth through a diversified product line.
See More
- Order Expansion: QTREX Quantum Ltd. has received a purchase order for an Additively Manufactured Electronics system from a Fortune 500 company, which will be delivered to a site outside the United States, marking an expansion of the company's commercial footprint with global enterprise customers.
- Technological Advantage: The AME system from QTREX is designed to create intricate structures in a single workflow, providing unique capabilities that conventional technologies cannot replicate, which is expected to drive applications in quantum computing infrastructure.
- Financial Impact: This order is anticipated to positively contribute to QTREX's upcoming financial results, further solidifying the company's position as an advanced AME platform in demanding technology environments.
- Market Outlook: The company is actively engaging with additional prospective tier-1 customers and expects to continue advancing its AME commercial pipeline and quantum infrastructure programs, establishing a stable commercial revenue base.
See More
- Financing Agreement: QTREX Quantum Ltd. has signed a securities purchase agreement with a new investor to issue 6,666,667 ordinary shares at $1.50 per share, expecting gross proceeds of approximately $10 million, which will be utilized for working capital and general corporate purposes, thereby enhancing the company's competitive edge in quantum hardware infrastructure.
- Accelerating Strategic Transformation: CEO Dagi Ben-Noon stated that this financing will accelerate the company's transformation into a quantum hardware infrastructure firm, particularly in commercializing its AME-based cryogenic interconnect platform, while enhancing R&D capabilities to support critical hardware applications.
- Registration Statement Commitment: Under a registration rights agreement with the investor, QTREX has committed to filing a registration statement with the SEC covering the resale of the ordinary shares and pre-funded warrants sold in the offering, ensuring future liquidity and market access.
- Market Outlook: QTREX is focused on developing high-density, thermally optimized quantum connectivity solutions, and in addition to quantum technology, the company is actively advancing its medical technology portfolio, indicating significant growth potential across multiple critical markets.
See More






